JP2024543204A5 - - Google Patents

Info

Publication number
JP2024543204A5
JP2024543204A5 JP2024532708A JP2024532708A JP2024543204A5 JP 2024543204 A5 JP2024543204 A5 JP 2024543204A5 JP 2024532708 A JP2024532708 A JP 2024532708A JP 2024532708 A JP2024532708 A JP 2024532708A JP 2024543204 A5 JP2024543204 A5 JP 2024543204A5
Authority
JP
Japan
Prior art keywords
glu
crosslink
aminomethyl
trp
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024532708A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543204A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/084077 external-priority patent/WO2023099669A1/en
Publication of JP2024543204A publication Critical patent/JP2024543204A/ja
Publication of JP2024543204A5 publication Critical patent/JP2024543204A5/ja
Pending legal-status Critical Current

Links

JP2024532708A 2021-12-01 2022-12-01 インターロイキン-23受容体のペプチド阻害剤 Pending JP2024543204A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21211815.2 2021-12-01
EP21211815 2021-12-01
PCT/EP2022/084077 WO2023099669A1 (en) 2021-12-01 2022-12-01 Peptide inhibitors of interleukin-23 receptor

Publications (2)

Publication Number Publication Date
JP2024543204A JP2024543204A (ja) 2024-11-19
JP2024543204A5 true JP2024543204A5 (cg-RX-API-DMAC7.html) 2025-12-05

Family

ID=78821013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024532708A Pending JP2024543204A (ja) 2021-12-01 2022-12-01 インターロイキン-23受容体のペプチド阻害剤

Country Status (12)

Country Link
US (1) US20250154198A1 (cg-RX-API-DMAC7.html)
EP (1) EP4440592A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024543204A (cg-RX-API-DMAC7.html)
KR (1) KR20240111800A (cg-RX-API-DMAC7.html)
CN (1) CN118354781A (cg-RX-API-DMAC7.html)
AU (1) AU2022402440A1 (cg-RX-API-DMAC7.html)
CA (1) CA3240982A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024001598A1 (cg-RX-API-DMAC7.html)
IL (1) IL313185A (cg-RX-API-DMAC7.html)
MX (1) MX2024006556A (cg-RX-API-DMAC7.html)
TW (1) TW202332682A (cg-RX-API-DMAC7.html)
WO (1) WO2023099669A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4471048A1 (en) * 2023-06-01 2024-12-04 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor
EP4471049A1 (en) * 2023-06-01 2024-12-04 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor
CN121794283A (zh) * 2023-09-08 2026-04-03 赛诺菲 作为选择性il-23受体抑制剂的新型肽
WO2026013260A1 (en) 2024-07-12 2026-01-15 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor
WO2026026815A1 (zh) * 2024-07-30 2026-02-05 西藏海思科制药有限公司 白介素-23受体的肽抑制剂及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295838B6 (cs) 1996-09-09 2005-11-16 Zealand Pharma A/S Způsob výroby peptidů
US8946150B2 (en) 2011-06-14 2015-02-03 Medical Diagnostic Laboratories, LLC. Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
SG10201810154WA (en) 2014-07-17 2018-12-28 Protagonist Therapeutics Inc Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
HK1257747A1 (zh) 2015-07-15 2019-10-25 Protagonist Therapeutics Inc. 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途
WO2018022937A1 (en) 2016-07-27 2018-02-01 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
US20200064357A1 (en) * 2016-11-09 2020-02-27 Protagonist Therapeutics, Inc. Methods for determining and monitoring gastrointestinal inflammation
JP2020505352A (ja) 2017-01-18 2020-02-20 プロタゴニスト セラピューティクス, インコーポレイテッド インターロイキン−23受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用
CA3104418A1 (en) 2018-07-12 2020-01-16 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
AU2020311395A1 (en) 2019-07-10 2022-02-03 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
MX2022008740A (es) * 2020-01-15 2022-09-23 Janssen Biotech Inc Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
WO2021146458A1 (en) 2020-01-15 2021-07-22 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
SMT202500254T1 (it) 2020-01-15 2025-09-12 Janssen Biotech Inc Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie

Similar Documents

Publication Publication Date Title
JP2025134806A (ja) インターロイキン23受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用
ES2977537T3 (es) Inhibidores peptídicos orales del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias intestinales
JP5364583B2 (ja) 合成ペプチドアミドおよびその二量体
ES2544573T3 (es) Inhibidores diméricos de afinidad elevada de PSD-95 y su uso para el tratamiento del daño cerebral isquémico y del dolor
CA3226492A1 (en) Bicyclic peptide inhibitors of interleukin-23 receptor
JPH10511086A (ja) 改善された環状crf作用薬
CN108929375A (zh) 拟肽大环化合物
ES2299253T3 (es) Peptidos basados en la secuencia de la lactoferrina humana y sus usos,.
CN104781276A (zh) 肽-树枝状聚合物结合物及其用途
JP2000503652A (ja) 合成il―10類似体
IE921689A1 (en) Terminally modified tri-, tetra- and pentapeptide¹anaphylatoxin receptor ligands
KR20240111800A (ko) 인터루킨-23 수용체의 펩티드 억제제
WO2020230780A1 (ja) Ras阻害ペプチド
JPH08503217A (ja) 血小板糖タンパク質▲II▼b/▲III▼aの阻害剤として有用な複素環式環により結合された環状化合物
CA2095360A1 (en) Modified hexa- and heptapeptide anaphylatoxin receptor ligands
JPH0676437B2 (ja) Grf類似体
KR20250028290A (ko) 선택적 il-23 수용체 길항제로서의 새로운 펩티드
JP2949129B2 (ja) 胃腸運動刺激活性を有するモチリン類似ポリペプチド
JP7698318B2 (ja) Vipr2アンタゴニストペプチド
JPS62123198A (ja) デカペプチド
JP2001518515A (ja) リウマチ性関節炎の治療組成物および治療方法
JP2003501443A (ja) ニューロメジンbおよびソマトスタチンレセプターアゴニスト
JP2017512799A (ja) 環状プロサポシンペプチドおよびその使用
JP2003500334A (ja) 抗hiv作用を有するrantes由来ペプチド
JP7032808B2 (ja) ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ